Suppr超能文献

微小RNA-30c-5p的下调通过乳腺癌中COTL1介导的微丝排列导致细胞迁移和肿瘤转移。

Downregulation of microRNA-30c-5p was responsible for cell migration and tumor metastasis via COTL1-mediated microfilament arrangement in breast cancer.

作者信息

Pei Bei, Li Tongyang, Qian Qi, Fan Wenqiang, He Xiao, Zhu Yulan, Xu Lingyun

机构信息

Changzhou No. 2 People's Hospital, Xinglong Lance, Changzhou, China.

Department of Breast Surgery, Changzhou No. 2 People's Hospital, Changzhou 213003, China.

出版信息

Gland Surg. 2020 Jun;9(3):747-758. doi: 10.21037/gs-20-472.

Abstract

BACKGROUND

Breast cancer metastasis is the main problem that affects the therapy and prognosis of breast cancer patients. Studies have indicated the role of microRNAs in breast cancer regulation, but the mechanisms are largely unknown.

METHODS

In this study, we determined the expression of microRNA-30c-5p (miR-30c-5p) and coactosin-like protein 1 () gene in breast cancer tissues, and revealed their effects on breast cancer metastasis regulation. Breast cancer and paracancerous tissues were collected. Reverse transcriptase polymerase chain reaction RT-PCR) was used to analyze the expression of miR-30c-5p and , and breast cancer cell line (MCF-7) was employed to verify the relationship between miR-30c-5p and COTL1. Western blot analysis and immunofluorescence were used for proteins analysis and microfilament observation, respectively. A dual-luciferase reporter gene was used for microRNA-gene interaction assay.

RESULTS

The results showed that the expression of miR-30c-5p decreased, while the expression of COTL1 increased in breast cancer tissues. The results of luciferase reporting gene assay showed that, COTL1 was the target of miR-30c-5p. After miR-30c-5p was upregulated, the expression of COTL1 was reduced, microfilament arrangement was in disorder, and cell migration ability was inhibited. After miR-30c-5p was downregulated, the expression of COTL1 was increased, and the cell migration ability was enhanced. COTL1 protein expression levels were significantly higher in cancer tissues with lymph node metastasis.

CONCLUSIONS

These findings indicate that miR-30c-5p/COTL1 pathway regulates breast cancer metastasis and can be used as a potential therapy target.

摘要

背景

乳腺癌转移是影响乳腺癌患者治疗和预后的主要问题。研究表明微小RNA在乳腺癌调控中发挥作用,但其机制尚不清楚。

方法

在本研究中,我们检测了微小RNA-30c-5p(miR-30c-5p)和类肌动蛋白结合蛋白1(COTL1)基因在乳腺癌组织中的表达,并揭示了它们对乳腺癌转移调控的影响。收集乳腺癌组织及癌旁组织。采用逆转录聚合酶链反应(RT-PCR)分析miR-30c-5p和COTL1的表达,并利用乳腺癌细胞系(MCF-7)验证miR-30c-5p与COTL1之间的关系。分别采用蛋白质免疫印迹分析和免疫荧光进行蛋白质分析和微丝观察。采用双荧光素酶报告基因进行微小RNA-基因相互作用检测。

结果

结果显示,乳腺癌组织中miR-30c-5p表达降低,而COTL1表达升高。荧光素酶报告基因检测结果表明,COTL1是miR-30c-5p的靶标。上调miR-30c-5p后,COTL1表达降低,微丝排列紊乱,细胞迁移能力受到抑制。下调miR-30c-5p后,COTL1表达增加,细胞迁移能力增强。有淋巴结转移的癌组织中COTL1蛋白表达水平显著更高。

结论

这些研究结果表明,miR-30c-5p/COTL1通路调控乳腺癌转移,可作为潜在的治疗靶点。

相似文献

2
MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1.
Biomed Pharmacother. 2017 Sep;93:554-560. doi: 10.1016/j.biopha.2017.06.084. Epub 2017 Jul 4.
6
miR-30c-5p inhibits esophageal squamous cell carcinoma progression by repressing the PI3K/AKT signaling pathway.
Thorac Cancer. 2024 Oct;15(30):2206-2216. doi: 10.1111/1759-7714.15427. Epub 2024 Sep 17.
7
miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
IUBMB Life. 2014 May;66(5):371-7. doi: 10.1002/iub.1273. Epub 2014 May 20.

引用本文的文献

1
LncRNA DDX11-AS1 promotes breast cancer progression by targeting the miR-30c-5p/MTDH axis.
Sci Rep. 2024 Nov 5;14(1):26745. doi: 10.1038/s41598-024-78413-3.
5
Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Mar 28;48(3):311-322. doi: 10.11817/j.issn.1672-7347.2023.220427.
9
Identification of a 12-Gene Signature and Hub Genes Involved in Kidney Wilms Tumor Integrated Bioinformatics Analysis.
Front Oncol. 2022 Apr 11;12:877796. doi: 10.3389/fonc.2022.877796. eCollection 2022.
10
Bone mesenchymal stem cell-derived extracellular vesicles containing NORAD promote osteosarcoma by miR-30c-5p.
Lab Invest. 2022 Aug;102(8):826-837. doi: 10.1038/s41374-021-00691-6. Epub 2022 Mar 24.

本文引用的文献

1
Role of MicroRNA-30c in cancer progression.
J Cancer. 2020 Feb 14;11(9):2593-2601. doi: 10.7150/jca.38449. eCollection 2020.
2
Hereditary breast cancer: screening and risk reducing surgery.
Gland Surg. 2019 Sep;8(Suppl 3):S142-S149. doi: 10.21037/gs.2019.04.04.
5
MiR-30c exerts tumor suppressive functions in colorectal carcinoma by directly targeting BCL9.
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3335-3343. doi: 10.26355/eurrev_201904_17696.
6
ATM-Mediated Phosphorylation of Cortactin Involved in Actin Polymerization Promotes Breast Cancer Cells Migration and Invasion.
Cell Physiol Biochem. 2018;51(6):2972-2988. doi: 10.1159/000496048. Epub 2018 Dec 14.
7
PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial-Mesenchymal Transition.
Clin Cancer Res. 2018 Dec 15;24(24):6319-6330. doi: 10.1158/1078-0432.CCR-18-1270. Epub 2018 Oct 10.
8
Precision medicine in breast cancer.
Chin Clin Oncol. 2018 Jun;7(3):29. doi: 10.21037/cco.2018.06.04.
10
Novel prognostic and predictive microRNA targets for triple-negative breast cancer.
FASEB J. 2018 May 29:fj201800120R. doi: 10.1096/fj.201800120R.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验